Empiriko is a biotechnology company focused on developing technologies for drug discovery and point-of-care devices. It offers a Biomimiks platform (in-vitro synthetic liver technology) to screen compounds for assessing drug metabolism and toxicity in the drug discovery and development process. The company also provides a personalized diagnostics platform, comprised of a personalized metabolic fingerprint (PMF) device, biomarkers, and predictive analytics, that enables clinicians to manage at-risk patients at home.